MARLENE LINDSAY: Open Payments
NPI 1336163823 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 17 payments from 9 companies in 2025. Trend: 2023 $950 · 2024 $647 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| PFIZER INC. | 1 | $29 |
| Lilly USA, LLC | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| Medicure Pharma Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
Products named: FARXIGA, TRELEGY ELLIPTA, AIRSUPRA, ELIQUIS, ZEPBOUND, Quviviq, BREZTRI, Zypitamag.
Industry payments across FL — which companies pay providers there.
